会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Endoderm, cardiac and neural inducing factors
    • 内胚层,心脏和神经诱导因子
    • US6133232A
    • 2000-10-17
    • US878474
    • 1997-06-18
    • Edward M. De RobertisTewis Bouwmeester
    • Edward M. De RobertisTewis Bouwmeester
    • C12N15/09A61K38/00C07K14/475C07K19/00A61K38/18C07K14/46
    • C07K14/475A61K38/00
    • Two novel proteins have been designated "cerberus" and "frzb-1," respectively. Cerberus is expressed as a secreted peptide during embryogenesis of the Xenopus embryo, and is expressed specifically in the head organizer region. This new molecule has endodermal, cardiac, and neural tissue inducing activity, that should prove useful in therapeutic, diagnostic, and clinical applications requiring regeneration, differentiation, or repair of these and other tissues. Frzb-1 is a soluble antagonist of growth factors of the Wnt family that acts by binding to Wnt growth factors in the extracellular space. A third novel protein is designated "PAPC" which promotes the formation of dorsal mesoderm and somites in the embryo.
    • 两种新型蛋白质分别被称为“cerberus”和“frzb-1”。 Cerberus在非洲爪蟾胚胎的胚胎发生期间被表达为分泌肽,并且在头部组织器区域中具体表达。 这种新分子具有内胚层,心脏和神经组织诱导活性,应该证明在需要这些和其他组织的再生,分化或修复的治疗,诊断和临床应用中是有用的。 Frzb-1是通过与细胞外空间中的Wnt生长因子结合而起作用的Wnt家族的生长因子的可溶性拮抗剂。 第三种新型蛋白质被命名为“PAPC”,其促进胚胎中背部中胚层和体细胞的形成。